Literature DB >> 15986133

Activated leukocyte cell adhesion molecule (ALCAM/CD166): signaling at the divide of melanoma cell clustering and cell migration?

Guido W M Swart1, Pim C Lunter, Jeroen W J van Kilsdonk, Leon C L T van Kempen.   

Abstract

Orchestrated modulation of cell adhesion is essential for development and homeostasis in multicellular organisms. It optimizes embedding of the cell in its dynamic environment and facilitates appropriate cell responses and intercellular communication. Chronic disturbance of this delicate equilibrium causes defects in tissue architecture and sometimes cancer. In tumor cell biology, dynamic control of adhesion molecules is important to proceed through the metastatic cascade and to allow cell release from the primary tumor, invasion of the surrounding matrix, intravasation and adhesion to vascular endothelial cells to facilitate extravasation. Intertwined and multiple adhesive interactions rather than individual interactions presumably play critical roles in neoplastic development. Yet, knowledge of the contribution of each individual adhesion molecule is essential to unravel this network of interactions. This review will focus on activated leukocyte cell adhesion molecule (ALCAM/CD166) and its role in human melanoma progression. It is hypothesized that ALCAM may function as a cell surface sensor to register local growth saturation and to regulate cellular signaling and dynamic responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15986133     DOI: 10.1007/s10555-005-1573-0

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  32 in total

1.  Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth.

Authors:  Irina Issaeva; Yulia Zonis; Tanya Rozovskaia; Kira Orlovsky; Carlo M Croce; Tatsuya Nakamura; Alex Mazo; Lea Eisenbach; Eli Canaani
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

2.  Cell Adhesion Molecule CD166 Drives Malignant Progression and Osteolytic Disease in Multiple Myeloma.

Authors:  Linlin Xu; Khalid S Mohammad; Hao Wu; Colin Crean; Bradley Poteat; Yinghua Cheng; Angelo A Cardoso; Christophe Machal; Helmut Hanenberg; Rafat Abonour; Melissa A Kacena; John Chirgwin; Attaya Suvannasankha; Edward F Srour
Journal:  Cancer Res       Date:  2016-09-07       Impact factor: 12.701

3.  Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer.

Authors:  Daxun Piao; Tao Jiang; Gavin Liu; Baosheng Wang; Jin Xu; Anlong Zhu
Journal:  Mol Biol Rep       Date:  2011-06-14       Impact factor: 2.316

4.  ALCAM/CD166 adhesive function is regulated by the tetraspanin CD9.

Authors:  Alvaro Gilsanz; Lorena Sánchez-Martín; María Dolores Gutiérrez-López; Susana Ovalle; Yesenia Machado-Pineda; Raquel Reyes; Guido W Swart; Carl G Figdor; Esther M Lafuente; Carlos Cabañas
Journal:  Cell Mol Life Sci       Date:  2012-09-30       Impact factor: 9.261

Review 5.  Cancer-initiating enriched cell lines from human glioblastoma: preparing for drug discovery assays.

Authors:  Miriam Romaguera-Ros; María Peris-Celda; Jorge Oliver-De La Cruz; Josefa Carrión-Navarro; Arantxa Pérez-García; Jose Manuel García-Verdugo; Angel Ayuso-Sacido
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

6.  Enhanced immunoPET of ALCAM-positive colorectal carcinoma using site-specific ⁶⁴Cu-DOTA conjugation.

Authors:  Richard Tavaré; Wei H Wu; Kirstin A Zettlitz; Felix B Salazar; Katelyn E McCabe; James D Marks; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2014-08-04       Impact factor: 1.650

7.  A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth.

Authors:  Merete Thune Wiiger; Hege B Gehrken; Øystein Fodstad; Gunhild M Maelandsmo; Yvonne Andersson
Journal:  Cancer Immunol Immunother       Date:  2010-07-16       Impact factor: 6.968

8.  Wnt-dependent epithelial transitions drive pharyngeal pouch formation.

Authors:  Chong Pyo Choe; Andres Collazo; Le A Trinh; Luyuan Pan; Cecilia B Moens; J Gage Crump
Journal:  Dev Cell       Date:  2013-01-31       Impact factor: 12.270

9.  Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer.

Authors:  M Burkhardt; E Mayordomo; K-J Winzer; F Fritzsche; T Gansukh; S Pahl; W Weichert; C Denkert; H Guski; M Dietel; G Kristiansen
Journal:  J Clin Pathol       Date:  2006-02-16       Impact factor: 3.411

10.  Characterization of gene expression profiles for different types of mast cells pooled from mouse stomach subregions by an RNA amplification method.

Authors:  Soken Tsuchiya; Yuki Tachida; Eri Segi-Nishida; Yasushi Okuno; Shigero Tamba; Gozoh Tsujimoto; Satoshi Tanaka; Yukihiko Sugimoto
Journal:  BMC Genomics       Date:  2009-01-20       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.